| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/07/2002 | WO2002018435A1 18 human secreted proteins |
| 03/07/2002 | WO2002018434A2 Proteins related to schizophrenia and uses thereof |
| 03/07/2002 | WO2002018433A1 Adhesive protein and uses thereof |
| 03/07/2002 | WO2002018432A2 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 03/07/2002 | WO2002018431A1 Nucleotide sequences which code for the oxyr gene |
| 03/07/2002 | WO2002018430A2 Nucleotide sequences which code for the metr and metz genes |
| 03/07/2002 | WO2002018429A1 Nucleotide sequences which code for the ccpa2 gene |
| 03/07/2002 | WO2002018428A2 Sequences which code for the sige gene of corynebacterium glutamicum |
| 03/07/2002 | WO2002018427A2 Nucleotide sequences which code for the cita gene |
| 03/07/2002 | WO2002018426A2 Rabbit hemorrhagic disease vaccine and antigens |
| 03/07/2002 | WO2002018425A2 '47324', a novel g-protein and uses therefor |
| 03/07/2002 | WO2002018424A2 Nucleic acids and polypeptides |
| 03/07/2002 | WO2002018423A1 Bioactive peptide for cell adhesion |
| 03/07/2002 | WO2002018422A1 Amino acid substitution mutants of interleukin 13 |
| 03/07/2002 | WO2002018421A2 Human and mouse e2-protein, nucleic acids coding therefor and uses thereof |
| 03/07/2002 | WO2002018420A2 Cofactors of the pregnane x receptor and methods of use |
| 03/07/2002 | WO2002018419A2 Nucleotide sequences which code for the ccpa1 gene |
| 03/07/2002 | WO2002018418A1 Antibodies specific for methylated lysines in histones |
| 03/07/2002 | WO2002018415A1 Protein with cap- and cellulose- binding activity |
| 03/07/2002 | WO2002018414A2 Haplotypes of the bf gene |
| 03/07/2002 | WO2002018413A2 Haplotypes of the scya2 gene |
| 03/07/2002 | WO2002018412A1 17 human secreted proteins |
| 03/07/2002 | WO2002018411A1 7 human secreted proteins |
| 03/07/2002 | WO2002018410A1 Haplotypes of the agtr1 gene |
| 03/07/2002 | WO2002018369A2 Peptidomimetic protease inhibitors |
| 03/07/2002 | WO2002017963A2 Modulators of intermediate conductance calcium-activated potassium (ikca) channel activity for treating sexual dysfunction |
| 03/07/2002 | WO2002017947A2 Use of t proteins for the differential characterization and treatment of lesions and tumors of the nervous system |
| 03/07/2002 | WO2002017902A1 Gene conferring resistance to the antibacterial 4,5-dihydroxy-2-cyclopenten-1-one (dhcp), the protein encoded by same, and applications thereof |
| 03/07/2002 | WO2002017711A2 Therapeutics and diagnostics based on a novel signal transduction system in platelets |
| 03/07/2002 | WO2001088165A8 Nucleotide sequences coding for signal transduction components involved in plant pathogen defence |
| 03/07/2002 | WO2001088092A3 Methods and materials relating to stem cell factor-like (scf-like) polypeptides and polynucleotides |
| 03/07/2002 | WO2001087329A8 Liquid pharmaceutical composition containing an erythropoietin derivate |
| 03/07/2002 | WO2001087233A3 Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions and method of use thereof |
| 03/07/2002 | WO2001085777A3 Therapeutic pore-forming peptides |
| 03/07/2002 | WO2001083695A3 Dna sequences encoding dystrophin minigenes and methods of use thereof |
| 03/07/2002 | WO2001079431A3 A novel polypeptide, a human pathway 15 protein with the huntingtine protein and the polynucleotide encoding the polypeptide |
| 03/07/2002 | WO2001079269A3 Lipid binding protein 4 |
| 03/07/2002 | WO2001076532A8 Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death |
| 03/07/2002 | WO2001075025A3 A novel polypeptide, human thyroglobuline 9 and the polynuceotide encoding the polypeptide |
| 03/07/2002 | WO2001075010A3 A novel polypeptide, human nuclear transduction protein 25 containing a structural atp/gtp domain |
| 03/07/2002 | WO2001075004A3 A novel polypeptide, ubiquitine 9 conjugation enzyme and the polynucleotide encoding the polypeptide |
| 03/07/2002 | WO2001074855A3 Compositions and methods for dendritic cell-based immunotherapy |
| 03/07/2002 | WO2001070970A3 Regulation of human opsin-related g protein-coupled receptor |
| 03/07/2002 | WO2001068865A3 Fish vaccine against piscirickettsia salmonis |
| 03/07/2002 | WO2001068856A3 Human transcription factor-like protein and nucleic acids encoding same |
| 03/07/2002 | WO2001068840A3 REGULATION OF HUMAN DIAZEPAM BINDING INHIBITOR/ACYL-CoA-LIKE PROTEIN |
| 03/07/2002 | WO2001068703A8 Human histamine h3 gene variant-2 |
| 03/07/2002 | WO2001066738A3 Nucleic acids, encoding human crsp1 and uses thereof |
| 03/07/2002 | WO2001064887A3 32705, 23224, 27423, 32700, 32712, novel human g-proteins |
| 03/07/2002 | WO2001064872A3 Gene 2465: methods and compositions for the diagnosis and treatment of cardiovascular, hepatic and bone disease |
| 03/07/2002 | WO2001062936A3 Bunyaviridal reaper proteins and uses therefor |
| 03/07/2002 | WO2001062788A3 Corneodesmosin based test and model for inflammatory disease |
| 03/07/2002 | WO2001060997A3 Male tissue-specific regulatory region and method of using same |
| 03/07/2002 | WO2001060983A3 Treatment for bone disorders |
| 03/07/2002 | WO2001060865A8 Novel proteins and nucleic acids encoding same |
| 03/07/2002 | WO2001059155A3 Interferon-alpha induced genes |
| 03/07/2002 | WO2001059114A3 Tumor suppressor gene, p47ing3 |
| 03/07/2002 | WO2001058949A3 Heterologous polypeptide of the tnf family |
| 03/07/2002 | WO2001058939A3 Novel invertase inhibitors and methods of use |
| 03/07/2002 | WO2001057233A3 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
| 03/07/2002 | WO2001057219A3 Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods |
| 03/07/2002 | WO2001057201A3 Root transcriptional factors and methods of use |
| 03/07/2002 | WO2001055335A3 Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides |
| 03/07/2002 | WO2001055331A3 thdF |
| 03/07/2002 | WO2001055219A3 scsCNTFR/NNT-1 FUSION PROTEIN |
| 03/07/2002 | WO2001055178A3 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 03/07/2002 | WO2001055177A3 Methods to identify ctl epitopes of hiv |
| 03/07/2002 | WO2001053468A3 Lipid metabolism enzymes and polynucleotides encoding them |
| 03/07/2002 | WO2001051636A3 Secreted proteins |
| 03/07/2002 | WO2001049842A3 Mutm orthologue and uses thereof |
| 03/07/2002 | WO2001046405A3 Modulation of pax-2 for controlled apoptosis or survival of cells |
| 03/07/2002 | WO2001046231A3 Polynucleotides and polypeptides encoded thereby |
| 03/07/2002 | WO2001043768A3 Vaccine composition comprising the toxoplasma protein sag3 |
| 03/07/2002 | WO2001042285A3 Extracellular matrix and cell adhesion proteins as well as genes encoding them |
| 03/07/2002 | WO2001042280A3 Short peptides from the b4 and b5 regions of protein kinases which selectively modulate protein activity |
| 03/07/2002 | WO2001040474A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/07/2002 | WO2001038533B1 G protein-coupled receptor-like receptors and modulators thereof |
| 03/07/2002 | WO2001038360A3 Novel hcv non-structural polypeptide |
| 03/07/2002 | WO2001034822A3 Control of post-transcriptional gene silencing in plants |
| 03/07/2002 | WO2001034774A3 Method for protection of mammalian cells by means of over-expressed g-2/m cell cycle coupler |
| 03/07/2002 | WO2001034645A3 Mutated il-13 molecules and their uses |
| 03/07/2002 | WO2001032874A3 Polypeptides and nucleic acids encoding same |
| 03/07/2002 | WO2001032692A3 Peptide mimics of conserved gonococcal epitopes and methods and compositions using them |
| 03/07/2002 | WO2001032197A3 Methods of using lp8, a pdgf-related protein, to treat musculoskeletal disorders |
| 03/07/2002 | WO2001031008A3 Human and rat fgf-20 genes and gene expression products |
| 03/07/2002 | WO2001031006A3 Serum amyloid a isoform from colostrum |
| 03/07/2002 | WO2001029220A3 Mage-a12 antigenic peptides and uses thereof |
| 03/07/2002 | WO2001029218A3 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 03/07/2002 | WO2001023539A3 Genes encoding sterol delta-15 reductase in plants |
| 03/07/2002 | WO2001021654A3 Syk kinase-associated cell cycle proteins, compositions and methods of use |
| 03/07/2002 | WO2001021647A3 Methods of screening for compounds that modulate the lsr-leptin interaction and their use in the prevention and treatment of obesity-related diseases |
| 03/07/2002 | WO2001019994A3 PLANT APOPTOSIS INDUCING FACTORS (AIFs) |
| 03/07/2002 | WO2001019870A3 Secreted soluble alpha2delta-2, alpha2delta-3, alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/07/2002 | WO2001016324A3 Methods and compositions of a novel serine protease inhibitor |
| 03/07/2002 | WO2001011086A3 Methods of screening for angiogenesis modulators |
| 03/07/2002 | WO2001011049A3 Methods and compositions concerning canine interleukin 5 |
| 03/07/2002 | WO2001009165A3 ACTIVATION OF PEPTIDE PRODRUGS BY hK2 |
| 03/07/2002 | WO2000056352A3 Reagents and methods useful for detecting diseases of the prostate |
| 03/07/2002 | US20020029395 Flowering locus T (FT) and genetically modified plants having delayed flower development |
| 03/07/2002 | US20020028915 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |